Phase I and registry study of autologous bone marrow concentrate evaluated in PDE5 inhibitor refractory erectile dysfunction

BACKGROUND: Bone marrow mononuclear cells have been successfully utilized for numerous regenerative purposes. In the current study, patients suffering from erectile dysfunction (ED) unresponsive to phosphodiesterase 5 inhibitors were administered autologous bone marrow concentrate delivered intracav...

Descripción completa

Detalles Bibliográficos
Autores principales: Bieri, Mark, Said, Elias, Antonini, Gabrielle, Dickerson, Donald, Tuma, Jorge, Bartlett, Courtney E., Patel, Amit N., Gershman, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958721/
https://www.ncbi.nlm.nih.gov/pubmed/31937310
http://dx.doi.org/10.1186/s12967-019-02195-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958721/
https://www.ncbi.nlm.nih.gov/pubmed/31937310
http://dx.doi.org/10.1186/s12967-019-02195-w

Ejemplares similares